Guro Lind's project group
We focus our research on the cancer epigenome and DNA methylation in particular. By integrating large-scale analyses with detailed candidate gene characterization we aim at identifying DNA methylation biomarkers with clinical impact.
The group is member of "CoE - Centre for Cancer Biomedicine".
 | |
| RESEARCH THEMES |
Identification of novel epigenetic biomarkers for early detection of gastrointestinal cancer
Identification and characterization of epigenetic master keys in cancer development
Group contact information:
Department of Cancer Prevention, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1737
Guro.Elisabeth.Lind@rr-research.no
Print this page [1304 visits]Christos Samakovlis: The molecular basis of airway maturation in Drosophila
Jan 17, 2012
Latest publications
Oncogenicity of the developmental transcription factor Sox9
Cancer Res (in press)
PubMed 22246670
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
Gut (in press)
PubMed 22213796
Risk assessment of coumarin using the bench mark dose (BMD) approach: Children in Norway which regularly eat oatmeal porridge with cinnamon may exceed the TDI for coumarin with several folds
Food Chem Toxicol (in press)
PubMed 22178604
More publications
